The holy grail
Watch why Dr. Arthur Agatston, inventor of the Coronary Calcium Score (CACS), has integrated Cleerly's CCTA analysis into his concierge medicine practice. Schedule a demo with Cleerly's team to learn more about Dr. Agatston's "dream technology."
What Calcium Scoring Can’t Tell You About Coronary Artery Disease Risk
While CACS identifies the presence of calcified plaque, Cleerly's AI-enabled CCTA analysis provides comprehensive visualization of both calcified and non-calcified coronary plaque as well as the severity of stenosis — offering the ability to stage and track heart disease progression using powerful artificial intelligence. AI-enabled CCTA evolves the CACS approach for a new, higher standard of heart care.
AI takes us beyond a score —
and transforms preventive heart care.
"What Cleerly has done is it allows me to know how all these risk factors are interacting in the individual patient so I can tailor my advice and my treatment to that individual patient. And I can also tell that patient that as we treat you, we're gonna have the confidence that we have stopped the disease, that we're doing a good job. With just calcium scanning alone, I wasn't able to do that."
Ready to learn more about how Dr. Agatston is integrating Cleerly into his practice? Watch his on-demand webinar now — The Holy Grail of Heart Attack Prevention: How AI-Based Cardiac Imaging Complements Calcium Scoring
Schedule a Demo
Experience why Dr. Agatston considers Cleerly to be "the holy grail of prevention" by booking your one-on-one demonstration to see how Cleerly’s AI-driven CCTA analysis provides multiple softwares in a single, seamless solution.